ドーパミン

危険有害性情報のコード(GHS)

• 絵表示(GHS)

  

• 注意喚起語

  Warning

• 危険有害性情報

  H302：飲み込むと有害

  H361：生殖能または胎児への悪影響のおそれの疑い

  H400：水生生物に強い毒性

  H410：長期的影響により水生生物に非常に強い毒性

• 注意書き

  P201：使用前に取扱説明書を入手すること。

  P202：全ての安全注意を読み理解するまで取り扱わないこ と。

  P264：取扱い後は皮膚をよく洗うこと。

  P264：取扱い後は手や顔をよく洗うこと。

  P270：この製品を使用する時に、飲食または喫煙をしないこ と。

  P273：環境への放出を避けること。

  P281：指定された個人用保護具を使用すること。

  P301+P312：飲み込んだ場合：気分が悪い時は医師に連絡する こと。

  P308+P313：暴露または暴露の懸念がある場合：医師の診断/手当てを 受けること。

  P330：口をすすぐこと。

  P391：漏出物を回収すること。

  P405：施錠して保管すること。

  P501：内容物/容器を．．．に廃棄すること。

ドーパミン 化学特性,用途語,生産方法

• 解説

  C8H11NO2(153.18)．4-(2-アミノエチル)-1,2-ベンゼンジオールともいう．チロシンから合成されるカテコールアミンの一種．それ自身神経伝達物質としてはたらくが，ノルアドレナリンやアドレナリンの前駆物質ともなっている．ドーパミン受容体ブロッカーが統合失調症に効き，逆にドーパミン補充療法がパーキンソン病に効く．パーキンソン病 (パーキンソン症候群 ) の患者ではドーパミン作動性神経系でドーパミンが不足しているため症状が現れる。そこでドーパミンの前駆物質であるL-ドーパを患者に投与する療法が試みられ，病状を軽減することに成功している。ドーパミンはさらに代謝を受けて生理活性物質として重要なノルアドレナリンやアドレナリンになる。森北出版「化学辞典（第2版）

• 解説

  化学式はC8H11NO2。化学物質名は2−ジヒドロキシフェニルエチルアミン。生理活性アミン，カテコールアミンの一種。ホルモン，神経伝達物質として重要なノルアドレナリン，アドレナリン合成の前駆体。L‐チロシンからドーパ(DOPA,3,4‐ジオキシフェニルアラニン)の脱炭酸反応によって作られる。ドーパミンβ‐オキシダーゼの作用によりノルアドレナリンとなる。副腎髄質，脳，交感神経系，肺，小腸，肝臓にも多く含まれている。水に易溶で，酸化されやすい不安定な化合物。酸性溶液では比較的安定。塩酸塩は白色結晶で，融点約245℃で分解。マメ科植物に遊離形で存在するが，動物では中枢神経や副腎髄質でチロシンからL−ドーパを経て生合成される。脳では，黒質や辺縁系などにドーパミン作動性のニューロンがあり，パーキンソン病では黒質でのドーパミン産生の低下がみられる。また，多くの向精神薬がドーパミン受容体に作用することが知られている。

• 用途

  ドーパミン（英: dopamine）は、中枢神経系に存在する神経伝達物質で、アドレナリン、ノルアドレナリンの前駆体でもある。運動調節、ホルモン調節、快の感情、意欲、学習などに関わる。セロトニン、ノルアドレナリン、アドレナリン、ヒスタミン、ドーパミンを総称してモノアミン神経伝達物質と呼ぶ。またドーパミンは、ノルアドレナリン、アドレナリンと共にカテコール基をもつためカテコールアミンとも総称される。医学?医療分野では日本語表記をドパミンとしている。

• 効能

  強心薬, ドパミン受容体作動薬

• 説明

  Dopamine, abbreviated DA, is a biosynthetic compound and neurotransmitter produced in the body from the amino acid tyrosine by several pathways. It is synthesized in the adrenal gland where it is a precursor to other hormones (see Epinephrine) and in several portions of the brain, principally the substantia nigra and hypothalamus.

• 来歴

  Dopamine is stored in vesicles in the brain’s presynaptic nerve terminals. It is closely associated with its immediate precursor, l-Dopa (levodopa). Casmir Funk (1884–1967) first synthesized Dopa in racemic form in 1911 and considered Dopa a vitamin. In 1913, Marcus Guggenheim, a biochemist from Hoff man-LaRoche, isolated l-Dopa from seedlings of Vicia faba, the Windsor bean plant native to northern Africa and southwest Asia. Guggenheim used beans from the garden of Felix Hoff man (1868–1946), the discoverer of aspirin. Guggenheim ingested a 2.5-gram dose of l-Dopa, resulting in nausea and vomiting; he also administered small dosages to animals and did not observe any signifi cant effects. This led him to believe that l-Dopa was biologically inactive. Studies commencing in 1927 reported that Dopa played a role in glucose metabolism and aff ected arterial blood pressure. Interest in dopamine accelerated in 1938 when the German physician and pharmacologist Peter Holtz (1902–1970) and co-workers discovered the enzyme l-Dopa decarboxylase and that it converted l-Dopa into dopamine in humans and animals. Research over the next two decades focused on l-Dopa’s role as a precursor to other catecholamine hormones, its vascular effects, and its role in brain chemistry.

• 使用

  Dopamine(3-Hydroxytyramine) is used as a drug to treat several conditions. It can be injected as a solution ofdopamine hydrochloride, such as in the drug Intropin. It is used as a stimulant to the heartmuscle to treat heart conditions; it also constricts the blood vessels, increasing systolic bloodpressure and improving blood flow through the body. Dopamine is used in renal medicationsto improve kidney function and urination. Dopamine dilates blood vessels in the kidneys,increasing the blood supply and promoting the fl ushing of wastes from the body. Dopamineis used to treat psychological disorders such as schizophrenia and paranoia.

• 定義

  dopamine: A catecholamine thatis a precursor in the synthesis of noradrenalineand adrenaline. It alsofunctions as a neurotransmitter inthe brain.

• 生物学の機能

  Quantitatively, dopamine is the most important of the biogenic amine neurotransmitters in the CNS.The three major distinct dopaminergic systems in the mammalian brain are categorized according to the lengths of the neurons. There is a system comprising ultrashort neurons within amacrine cells of the retina and periglomerular cells in the olfactory bulb. Of the several intermediate-length dopaminergic neuronal systems, the best studied are neurons in the tuberobasal ventral hypothalamus that innervate the median eminence and the intermediate lobe of the pituitary. These neurons are important in the regulation of various hypothalamohypophysial functions, including prolactin release from the anterior pituitary.The best-categorized of the dopamine neuronal systems are the long projections from nuclei in the substantia nigra and ventral tegmental areas to the limbic cortex; other limbic structures, including the amygdaloid complex and piriform cortex; and the neostriatum (primarily the caudate and putamen). In Parkinson’s disease, the primary biochemical feature is a marked reduction in the concentration of dopamine in this long projection system.
  Several classes of drugs, notably the antipsychotics, discussed in Chapter 34, interfere with dopaminergic transmission. In general, dopamine appears to be an inhibitory neurotransmitter. Five dopamine receptors have been identified; the most important and best studied are the D₁- and D₂-receptor groups.The D1-receptor, which increases cyclic adenosine monophosphate (cAMP) by activation of adenylyl cyclase, is located primarily in the region of the putamen, nucleus accumbens, and in the olfactory tubercle. The D₂-receptor decreases cAMP, blocks certain calcium channels, and opens certain potassium channels.

• 一般的な説明

  Dopamine (Intropin) acts primarily on 1-and 1-adrenergic receptors, increasing systemic vascularresistance and exerting a positive inotropic effect on theheart. It must be administered by an intravenous route, becauseoral administration results in rapid metabolism byMAO and/or catechol-O-methyltransferase (COMT).

• 作用機序

  Dopamine is found in every sympathetic neuron and ganglion in the CNS. As a drug, and in addition to stimulation of dopaminergic receptors, dopamine indirectly stimulates both α- and β-adrenoreceptors. Dopamine also causes a release of endogenous norepinephrine. The mechanism of action is based on the excitatory effect on β-adrenoreceptors (in low and moderate doses), as well as on α-adrenoreceptors (in large doses). It has a positive inotropic effect on the heart, increases blood supply, selectively widens renal and mesenteric blood vessels, does not elevate blood pressure, and slightly increases the frequency of heartbeats.

• 臨床応用

  Although not strictly an adrenergic drug, dopamine is a catecholamine with properties related to the cardiovascular activities of the other agents in this chapter. Dopamine acts on specific dopamine receptors to dilate renal vessels, increasing renal blood flow. Dopamine also stimulates cardiac β1-receptors through both direct and indirect mechanisms. It is used to correct hemodynamic imbalances induced by conditions such as shock, myocardial infarction, trauma, or congestive heart failure. As a catechol and primary amine, dopamine is rapidly metabolized by COMT and MAO and, similar to dobutamine, has a short duration of action with no oral activity. It is administered as an intravenous infusion.

• 環境運命予測

  Dopamine quinones may irreversibly alter protein function through the formation of 5-cysteinyl-catechols on the proteins. The formation of dopamine quinone-alpha-synuclein consequently increases cytotoxic protofibrils and the covalent modification of tyrosine hydroxylase by dopamine quinones. The melaninsynthetic enzyme tyrosinase in the brain may rapidly oxidize excess amounts of cytosolic dopamine and prevent slowly progressive cell damage by auto-oxidation of dopamine, thus maintaining dopamine levels.

ドーパミン 上流と下流の製品情報

ドーパミン 生産企業

Global(163)Suppliers

51-61-6, ドーパミン キーワード